Sanguine BioSciences' Series A - II Round

Sanguine BioSciences raised a round of funding on September 01, 2015. Investors include FundersClub.

Sanguine BioSciences is a biotechnology company bridging the gap between patients and researchers by providing transparency throughout the personalized medicine R&D process. Sanguine collects and de-i…

Articles about Sanguine BioSciences' Series A - II Round: